Sandoz and attorneys for the plaintiffs, "end-purchasers" including consumers who bought Sandoz drugs from pharmacies, did not immediately respond to requests for comment. The settlement period ...

The US shift toward steep tariffs will likely make drugs more expensive and limit access for patients, according to one of ...

(Bloomberg) -- Sandoz Group AG plans to launch a semaglutide generic drug in Canada when the patent for the main ingredient ...

Sandoz and Ares – a subsidiary of OpGen ... fears of increasing numbers of infections that will resist all current drugs. The generics unit has been however extending its product range ...

with 500 million patients across more than 100 countries treated with Sandoz drugs. Generics and biosimilars account for an estimated 80% of medicines used worldwide by volume, at about 25% of the ...

This leaflet answers some common questions about Cyclosporin Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Biosimilars are designed to be as effective and safe as the original drugs but are considerably cheaper—Tyruko costs an average of 72% less than Tysabri. The extent of the issue remains unclear.

Like rivals Teva Pharmaceutical Industries Ltd. and Viatris Inc., Sandoz copies branded drugs once they lose patent protection, which leads to reduced costs. It manufactures those products largely ...